We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPA
326
DELISTED
Sparton
SPA
| $1.07M | 0.1% |
37,657
+24,820
| +193% | +$640K |
|
|
ARC
327
DELISTED
ARC Document Solutions, Inc.
ARC
| $1.07M | 0.1% |
104,342
-16,517
| -14% | -$159K |
|
|
ECHO
328
EchoStar
ECHO
$25.2B
| $1.06M | 0.1% |
25,042
-43,436
| -63% | -$1.73M |
|
329
Calix
CALX
$2.26B
| $1.06M | 0.1% |
+105,893
| New | +$1.05M |
|
330
LivePerson
LPSN
$20.2M
| $1.05M | 0.1% |
4,975
+4,138
| +494% | +$850K |
|
331
Universal Electronics
UEIC
$57.3M
| $1.05M | 0.1% |
16,141
-28,137
| -64% | -$1.62M |
|
|
POZN
332
DELISTED
POZEN INC
POZN
| $1.05M | 0.1% |
130,963
+54,531
| +71% | +$468K |
|
333
Selective Insurance
SIGI
$5.66B
| $1.04M | 0.1% |
38,350
+5,701
| +17% | +$145K |
|
334
NACCO Industries
NC
$360M
| $1.03M | 0.1% |
76,313
-29,396
| -28% | -$378K |
|
|
MYCC
335
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $1.02M | 0.1% |
57,093
+39,560
| +226% | +$745K |
|
|
BRSS
336
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $1.02M | 0.1% |
77,629
+30,471
| +65% | +$402K |
|
337
Harte-Hanks
HHS
| $1.02M | 0.1% |
13,192
+8,807
| +201% | +$576K |
|
338
Acco Brands
ACCO
$382M
| $1.02M | 0.1% |
+112,903
| New | +$931K |
|
|
ACAT
339
DELISTED
Arctic Cat Inc
ACAT
| $1.02M | 0.1% |
28,657
-18
| -0.1% | -$593 |
|
|
HEES
340
DELISTED
H&E Equipment Services
HEES
| $1.01M | 0.1% |
36,032
-67,141
| -65% | -$2.28M |
|
341
Rexford Industrial Realty
REXR
$8.68B
| $1.01M | 0.1% |
+64,299
| New | +$967K |
|
342
AZZ Inc
AZZ
$4.45B
| $1.01M | 0.1% |
+21,464
| New | +$968K |
|
|
NGHC
343
DELISTED
National General Holdings Corp
NGHC
| $1M | 0.1% |
53,911
+41,070
| +320% | +$762K |
|
|
FNFV
344
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $1M | 0.1% |
+83,511
| New | +$896K |
|
345
FTI Consulting
FCN
$4.87B
| $999K | 0.1% |
+25,871
| New | +$984K |
|
|
NXGN
346
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $991K | 0.09% |
63,536
+35,824
| +129% | +$524K |
|
|
JIVE
347
DELISTED
Jive Software, Inc.
JIVE
| $990K | 0.09% |
164,201
+51,009
| +45% | +$305K |
|
|
MPT
348
Medical Properties Trust
MPT
$2.93B
| $989K | 0.09% |
+71,776
| New | +$961K |
|
349
Popular Inc
BPOP
$11B
| $987K | 0.09% |
+28,988
| New | +$909K |
|
|
VRE
350
DELISTED
Veris Residential
VRE
| $985K | 0.09% |
+51,661
| New | +$989K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.